Logo image of MNDY

MONDAY.COM LTD (MNDY) Stock Fundamental Analysis

NASDAQ:MNDY - Nasdaq - IL0011762130 - Common Stock - Currency: USD

307.4  +7.54 (+2.51%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MNDY. MNDY was compared to 282 industry peers in the Software industry. While MNDY has a great health rating, its profitability is only average at the moment. MNDY is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year MNDY was profitable.
MNDY had a positive operating cash flow in the past year.
In the past 5 years MNDY reported 4 times negative net income.
MNDY had a positive operating cash flow in 4 of the past 5 years.
MNDY Yearly Net Income VS EBIT VS OCF VS FCFMNDY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

MNDY has a Return On Assets of 2.86%. This is in the better half of the industry: MNDY outperforms 72.34% of its industry peers.
Looking at the Return On Equity, with a value of 4.79%, MNDY is in the better half of the industry, outperforming 72.34% of the companies in the same industry.
Industry RankSector Rank
ROA 2.86%
ROE 4.79%
ROIC N/A
ROA(3y)-3.8%
ROA(5y)-26.94%
ROE(3y)-5.74%
ROE(5y)-222.32%
ROIC(3y)N/A
ROIC(5y)N/A
MNDY Yearly ROA, ROE, ROICMNDY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

The Profit Margin of MNDY (5.08%) is better than 71.99% of its industry peers.
MNDY's Gross Margin of 89.49% is amongst the best of the industry. MNDY outperforms 97.52% of its industry peers.
MNDY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 5.08%
GM 89.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y1.09%
MNDY Yearly Profit, Operating, Gross MarginsMNDY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

8

2. Health

2.1 Basic Checks

MNDY does not have a ROIC to compare to the WACC, probably because it is not profitable.
MNDY has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MNDY has been increased compared to 5 years ago.
MNDY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MNDY Yearly Shares OutstandingMNDY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
MNDY Yearly Total Debt VS Total AssetsMNDY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

MNDY has an Altman-Z score of 13.38. This indicates that MNDY is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of MNDY (13.38) is better than 88.65% of its industry peers.
There is no outstanding debt for MNDY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 13.38
ROIC/WACCN/A
WACC9.52%
MNDY Yearly LT Debt VS Equity VS FCFMNDY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

MNDY has a Current Ratio of 2.57. This indicates that MNDY is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.57, MNDY is in the better half of the industry, outperforming 71.28% of the companies in the same industry.
MNDY has a Quick Ratio of 2.57. This indicates that MNDY is financially healthy and has no problem in meeting its short term obligations.
MNDY has a Quick ratio of 2.57. This is in the better half of the industry: MNDY outperforms 71.63% of its industry peers.
Industry RankSector Rank
Current Ratio 2.57
Quick Ratio 2.57
MNDY Yearly Current Assets VS Current LiabilitesMNDY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

8

3. Growth

3.1 Past

MNDY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 71.86%, which is quite impressive.
The Revenue has grown by 32.25% in the past year. This is a very strong growth!
MNDY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 65.58% yearly.
EPS 1Y (TTM)71.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.33%
Revenue 1Y (TTM)32.25%
Revenue growth 3Y46.65%
Revenue growth 5Y65.58%
Sales Q2Q%30.12%

3.2 Future

MNDY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.22% yearly.
MNDY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.95% yearly.
EPS Next Y11.36%
EPS Next 2Y15.75%
EPS Next 3Y19.79%
EPS Next 5Y23.22%
Revenue Next Year26.71%
Revenue Next 2Y24.96%
Revenue Next 3Y24.2%
Revenue Next 5Y23.95%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MNDY Yearly Revenue VS EstimatesMNDY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B 4B
MNDY Yearly EPS VS EstimatesMNDY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 5 10 15 20

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 77.43, MNDY can be considered very expensive at the moment.
MNDY's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.45. MNDY is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 65.93, MNDY can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as MNDY.
When comparing the Price/Forward Earnings ratio of MNDY to the average of the S&P500 Index (21.90), we can say MNDY is valued expensively.
Industry RankSector Rank
PE 77.43
Fwd PE 65.93
MNDY Price Earnings VS Forward Price EarningsMNDY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MNDY.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MNDY indicates a somewhat cheap valuation: MNDY is cheaper than 61.35% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 49.79
EV/EBITDA 2194.94
MNDY Per share dataMNDY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as MNDY's earnings are expected to grow with 19.79% in the coming years.
PEG (NY)6.82
PEG (5Y)N/A
EPS Next 2Y15.75%
EPS Next 3Y19.79%

More info and screens

0

5. Dividend

5.1 Amount

MNDY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONDAY.COM LTD

NASDAQ:MNDY (7/3/2025, 7:50:35 PM)

307.4

+7.54 (+2.51%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-12 2025-05-12/bmo
Earnings (Next)08-11 2025-08-11/bmo
Inst Owners83.31%
Inst Owner Change1.72%
Ins Owners14.24%
Ins Owner ChangeN/A
Market Cap15.61B
Analysts83.23
Price Target357.65 (16.35%)
Short Float %7.86%
Short Ratio5.94
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)43.51%
Min EPS beat(2)34.04%
Max EPS beat(2)52.99%
EPS beat(4)4
Avg EPS beat(4)45.62%
Min EPS beat(4)31.58%
Max EPS beat(4)63.89%
EPS beat(8)8
Avg EPS beat(8)84.2%
EPS beat(12)12
Avg EPS beat(12)100.51%
EPS beat(16)16
Avg EPS beat(16)87.25%
Revenue beat(2)2
Avg Revenue beat(2)0.43%
Min Revenue beat(2)0.34%
Max Revenue beat(2)0.52%
Revenue beat(4)3
Avg Revenue beat(4)0.51%
Min Revenue beat(4)-0.01%
Max Revenue beat(4)1.19%
Revenue beat(8)7
Avg Revenue beat(8)0.85%
Revenue beat(12)11
Avg Revenue beat(12)1.55%
Revenue beat(16)15
Avg Revenue beat(16)3.18%
PT rev (1m)-0.85%
PT rev (3m)-8.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.85%
EPS NY rev (1m)0.32%
EPS NY rev (3m)11.05%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.65%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.48%
Valuation
Industry RankSector Rank
PE 77.43
Fwd PE 65.93
P/S 15.05
P/FCF 49.79
P/OCF 47.14
P/B 14.17
P/tB 14.17
EV/EBITDA 2194.94
EPS(TTM)3.97
EY1.29%
EPS(NY)4.66
Fwd EY1.52%
FCF(TTM)6.17
FCFY2.01%
OCF(TTM)6.52
OCFY2.12%
SpS20.43
BVpS21.69
TBVpS21.69
PEG (NY)6.82
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.86%
ROE 4.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 5.08%
GM 89.49%
FCFM 30.22%
ROA(3y)-3.8%
ROA(5y)-26.94%
ROE(3y)-5.74%
ROE(5y)-222.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y1.09%
F-Score6
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 140.28%
Cap/Sales 1.7%
Interest Coverage N/A
Cash Conversion 5206.48%
Profit Quality 594.55%
Current Ratio 2.57
Quick Ratio 2.57
Altman-Z 13.38
F-Score6
WACC9.52%
ROIC/WACCN/A
Cap/Depr(3y)155.37%
Cap/Depr(5y)251.28%
Cap/Sales(3y)2.22%
Cap/Sales(5y)2.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.33%
EPS Next Y11.36%
EPS Next 2Y15.75%
EPS Next 3Y19.79%
EPS Next 5Y23.22%
Revenue 1Y (TTM)32.25%
Revenue growth 3Y46.65%
Revenue growth 5Y65.58%
Sales Q2Q%30.12%
Revenue Next Year26.71%
Revenue Next 2Y24.96%
Revenue Next 3Y24.2%
Revenue Next 5Y23.95%
EBIT growth 1Y70.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year32.71%
EBIT Next 3Y36.71%
EBIT Next 5Y39.02%
FCF growth 1Y397.44%
FCF growth 3Y384.57%
FCF growth 5YN/A
OCF growth 1Y299.96%
OCF growth 3Y166.91%
OCF growth 5YN/A